THEY SAID IT! HOUSE LAWMAKERS MAINTAIN COMMITMENT TO BIPARTISAN COOPERATION ON DRUG PRICING
Sep 26, 2019
House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma… Read More
© 2024 CSRXP- All Rights Reserved
Updates
ICYMI: An Unprecedented Opportunity for Washington to Lower Drug Prices
Sep 25, 2019
An Unprecedented Opportunity for Washington to Lower Drug Prices Lauren… Read More
CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus
Sep 23, 2019
Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of… Read More
THEY SAID IT! LAWMAKERS SLAM BIG PHARMA FOR “GAMING THE SYSTEM” TO BLOCK COMPETITION
Sep 20, 2019
Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action… Read More
CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable
Sep 19, 2019
Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from… Read More
CSRxP: HHS OIG REPORT DRASTICALLY UNDERCUTS BIG PHARMA’S BLAME GAME AT CRITICAL MOMENT IN WASHINGTON
Sep 13, 2019
Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes,… Read More
NEW STUDY: BIG PHARMA PRICE-GOUGING MEDICATIONS FOR RARE DISEASES AT STAGGERING RATE
Sep 11, 2019
Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs… Read More
Big Pharma Watch: Drug Maker Hit With $15 Million Penalty for Illegal Price Hike Scheme
Sep 10, 2019
In case you missed it, a recent article in HealthLeaders details how brand… Read More
Going Boldly To The Bottom: Poll Finds Opinion Of Big Pharma Hits Record Low
Sep 3, 2019
Americans Have Negative View of Drug Makers by Two-to-One Margin… Read More
What They Are Saying: Americans Urge Action to Lower Drug Prices, Hold Big Pharma Accountable
Aug 29, 2019
Voices From Around the Country Call for Congress to Pass Senate Finance… Read More
Big Pharma Watch: How Drug Makers Use Charities to Pad Their Bottom Line
Aug 29, 2019
In case you missed it, a recent article in The Economist digs into the inner… Read More
Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability
Aug 22, 2019
BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more… Read More